Susquehanna Fundamental Investments, LLC Amicus Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $313,709 - $407,311	-31,946 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.89 - $12.48 $1.56 Million - $2.47 Million	-198,240 Reduced 86.12%	31,946 $303,000
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $871,957 - $1.1 Million	88,794 Added 62.8%	230,186 $2.66 Million
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $113,287 - $153,470	12,962 Added 10.09%	141,392 $1.35 Million
Q2 2021 Aug 11, 2021	BUY	$8.71 - $10.72 $984,822 - $1.21 Million	113,068 Added 736.02%	128,430 $1.24 Million
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $1.13 Million - $2.93 Million	-122,986 Reduced 88.9%	15,362 $152,000
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $9,078 - $16,775	-674 Reduced 0.48%	138,348 $3.19 Million
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $732,435 - $902,901	56,822 Added 69.13%	139,022 $1.96 Million
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $728,292 - $1.29 Million	82,200 New	82,200 $1.24 Million

312

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.64B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.